NCT00304772View on ClinicalTrials.gov

Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients

PHASE4WithdrawnINTERVENTIONAL

0

Timeline

Start Date

August 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

CandidiasisSepsis

Interventions

DRUG

Fluconazole

400mg/day

DRUG

Micafungin

150mg/day

Trial Locations (1)

606-8507

Department of Clinical Laboratory Medicine, Kyoto University Hospital, Kyoto

Sponsors

Collaborators (2)

Astellas Pharma Inc

All Listed Sponsors

lead

Kyoto University

OTHER

collaborator

Pfizer

INDUSTRY

collaborator

Astellas Pharma Inc

INDUSTRY